Skip to main content
Caplight Logo









Vistel

Vistel

Private
BeijingHealthcare & Life Scienceshttps://vistel.cn/

Last Round

Series E

Extension

Mar 28, 2022

Total Funding Raised

$207.16M

Company Overview

Vistel is a high-tech medical technology company that develops AI-driven diagnostic systems and smart ophthalmic hardware for eye disease screening and management.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Telemedicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

ophthalmic imagingmedical AIfundus image analysistelemedicineeye disease screeningAI diagnosticsophthalmology softwaremedical imaging AIdigital healthhealthtechclinical decision supportCDSmedical deviceretinal screeningSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vistel Comparables

Compare Vistel with similar companies based on industry and business-model similarity.

Vistel comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Airdoc
87%
EyRIS Pte Ltd
86%
VoxelCloud
83%

Vistel Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series E ExtensionMar 28, 2022
Series EMar 17, 2021
Series DSep 1, 2020
Series CNov 1, 2019
Series BSep 5, 2017
Series A
Jun 12, 2016

Key People

Founding team and executive leadership

卢开宇

CFO

Executive Team

Vistel Investors

Notable investors and investment history

Vistel investors
InvestorRounds
V FundSeries D, Series E
Hillhouse InvestmentSeries B, Series C
Cloud Angel FundAngel
Northern Light Venture CapitalSeries B, Series A, Angel
CICC CapitalSeries D
如山资本Series B
CDH InvestmentsSeries E Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 28, 2022

    $47.3M round led by CDH Investments

  • Nov 1, 2019

    $14.2M round led by Hillhouse Investment

Vistel Filings

Explore SEC and related filing metadata, where available.

Vistel filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vistel's valuation, stock price, and market status.

Is Vistel a public or private company?

Vistel is a private company.

What is the current stock price of Vistel?

Vistel is a private company with no public stock price. No recent secondary market data is available.

How much is Vistel worth (valuation)?

Valuation information for Vistel is not publicly available.

Can I buy Vistel stock?

Vistel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vistel's last funding round?

Vistel's most recent funding round was Series E Extension on March 28, 2022.

Who are the main investors in Vistel?

Key investors in Vistel include Hillhouse Investment, Northern Light Venture Capital, CDH Investments, CPE.

Will Vistel IPO soon?

No public IPO plans have been announced for Vistel.

How can I track Vistel secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vistel's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Employee Range13
Year Founded2016
Last FundingMar 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?